Detection of pattern of myocardial fibrosis by contrast-enhanced MRI: Is redefinition of uremic cardiomyopathy necessary for management of patients?

Kidney International

Volumn 69, Issue 10, 2006, Pages 1711-1712

  Aoki, J ^a   Hara, K ^a  

^a MITSUI MEMORIAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

CARDIOMYOPATHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFUSE LATE GADOLINIUM ENHANCEMENT; ECHOCARDIOGRAPHY; FOCAL LATE GADOLINIUM ENHANCEMENT; HEART MUSCLE FIBROSIS; HEART MUSCLE REVASCULARIZATION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; UREMIA; UREMIC CARDIOMYOPATHY;

EID: 33646700763     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000259     Document Type: Note

References (10)

1. Tyralla K, Amann K. Morphology of the heart and arteries in renal failure. Kidney Int Suppl 2003; 84: S80-S83.
2. Aoki J, Ikari Y, Nakajima H et al. Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney Int 2005; 67: 333-340.
3. Mollet NR, Cademartiri F, van Mieghem CA et al. High-resolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography. Circulation 2005; 112: 2318-2323.
4. Smedema JP, Snoep G, van Kroonenburgh MP et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005; 45: 1683-1690.
5. Maceira AM, Joshi J, Prasad SK et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005; 111: 186-193.
6. Moon JC, Reed E, Sheppard MN et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004; 43: 2260-2264.
7. Mark PB, Johnston N, Groenning BA et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 2006; 69: 1839-1845.
8. Kim RJ, Wu E, Rafael A et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-1453.
9. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 2002; 106: 2207-2211.
10. Halkin A, Mehran R, Casey CW et al. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial. Am Heart J 2005; 150: 1163-1170.